CompletedPhase 3NCT00299325

VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sanofi
Principal Investigator
Valérie Pilorget, MD
Sanofi
Intervention
Rimonabant(drug)
Enrollment
254 target
Eligibility
35-70 years · All sexes
Timeline
20062008

Study locations (9)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00299325 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials